医院间竞争与颅脑神经外科患者住院费用及成本的关系
该研究基于2006年和2009年美国全国住院患者样本,纳入472,938例颅脑神经外科住院患者,采用赫芬达尔-赫希曼指数(HHI)衡量医院间竞争程度。结果显示,竞争更激烈的市场医院收费更高,但成本(实际资源使用)除脑脊液分流手术外无显著差异,且竞争与多数临床结局无关,仅脑肿瘤手术死亡率可能降低。
要点
- 竞争更激烈(HHI每降低0.1)与颅脑手术住院收费增加7%相关(β=1.07,p<0.001)。
- 竞争与住院成本无显著关联,仅脑脊液分流手术成本增加3%(β=1.03,p=0.021)。
- 竞争未改善多数临床结局,但脑肿瘤手术死亡率可能降低(OR 0.78,p=0.026)。
核心结论
- 竞争更激烈的市场医院对颅脑手术住院患者收费更高,但成本除脑脊液分流外无显著增加。
- 竞争加剧未带来结局改善,仅脑肿瘤手术可能生存获益。
研究设计与样本
- 基于美国全国住院患者样本2006年和2009年数据,纳入472,938例颅脑神经外科住院患者,涉及896家医院。
- 采用HHI量化医院间竞争,多变量回归分析HHI与住院收费及成本的关联,控制17项患者、医院、严重程度和经济因素。
主要发现
- HHI范围0.099–0.724(均值0.298±0.105),竞争更激烈市场医院收费/成本加成更高(β=1.10,p<0.001)。
- 2006至2009年平均收费从$62,098增至$77,812(p<0.001),成本从$21,385增至$22,389(p<0.001)。
- HHI每降低0.1(竞争增加)与总住院收费增加7%(β=1.07,p<0.001)及多个亚专业收费增加相关。
- HHI与总成本无显著关联,仅脑脊液分流手术成本增加3%(β=1.03,p=0.021)。
- 竞争增加与住院死亡率、出院去向或并发症率无关,但脑肿瘤死亡率降低(OR 0.78,p=0.026),总住院时间延长(β=1.06,p<0.001)。
临床怎么用
- 在竞争激烈地区,颅脑神经外科住院收费可能更高,但实际资源使用(成本)未必增加。
- 竞争加剧未必带来临床结局改善,政策制定需关注收费与成本的分离现象。
局限性
- 研究为回顾性分析,仅纳入2006年和2009年数据,结论外推需谨慎。
- 成本通过收费乘以成本收费比估算,可能存在测量偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Research has documented significant growth in neurosurgical expenditures and practice consolidation. The authors evaluated the relationship between interhospital competition and inpatient charges or costs in patients undergoing cranial neurosurgery. METHODS: The authors identified all admissions in 2006 and 2009 from the National Inpatient Sample. Admissions were classified into 5 subspecialties: cerebrovascular, tumor, CSF diversion, neurotrauma, or functional. Hospital-specific interhospital competition levels were quantified using the Herfindahl-Hirschman Index (HHI), an economic metric ranging continuously from 0 (significant competition) to 1 (monopoly). Inpatient charges (hospital billing) were multiplied with reported cost-to-charge ratios to calculate costs (actual resource use). Multivariate regressions were used to assess the association between HHI and inpatient charges or costs separately, controlling for 17 patient, hospital, severity, and economic factors. The reported β-coefficients reflect percentage changes in charges or costs (e.g., β-coefficient = 1.06 denotes a +6% change). All results correspond to a standardized -0.1 change in HHI (increase in competition). RESULTS: In total, 472,938 nationwide admissions for cranial neurosurgery treated at 896 unique hospitals met inclusion criteria. Hospital HHIs ranged from 0.099 to 0.724 (mean 0.298 ± 0.105). Hospitals in more competitive markets had greater charge/cost markups (β-coefficient = 1.10, p < 0.001) and area wage indices (β-coefficient = 1.04, p < 0.001). Between 2006 and 2009, average neurosurgical charges and costs rose significantly ($62,098 to $77,812, p < 0.001; $21,385 to $22,389, p < 0.001, respectively). Increased interhospital competition was associated with greater charges for all admissions (β-coefficient = 1.07, p < 0.001) as well as cerebrovascular (β-coefficient = 1.08, p < 0.001), tumor (β-coefficient = 1.05, p = 0.039), CSF diversion (β-coefficient = 1.08, p < 0.001), neurotrauma (β-coefficient = 1.07, p < 0.001), and functional neurosurgery (β-coefficient = 1.11, p = 0.037) admissions. However, no significant associations were observed between HHI and costs, except for CSF diversion surgery (β-coefficient = 1.03, p = 0.021). Increased competition was not associated with important clinical outcomes, such as inpatient mortality, favorable discharge disposition, or complication rates, except for lower mortality for brain tumors (OR 0.78, p = 0.026), but was related to greater length of stay for all admissions (β-coefficient = 1.06, p < 0.001). For a sensitivity analysis adjusting for outcomes, all findings for charges and costs remained the same. CONCLUSIONS: Hospitals in more competitive markets exhibited higher charges for admissions of patients undergoing an in-hospital cranial procedure. Despite this, interhospital competition was not associated with increased inpatient costs except for CSF diversion surgery. There was no corresponding improvement in outcomes with increased competition, with the exception of a potential survival benefit for brain tumor surgery.
引用
- Tang OY, Rivera Perla KM, Lim RK, et al. Interhospital competition and hospital charges and costs for patients undergoing cranial neurosurgery. J Neurosurg. 2020. PMID: 33007751. doi:10.3171/2020.6.JNS20732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。